SEC Info - CymaBay Therapeutics, Inc. - ‘S-1MEF’ on 7/21/14

SEC Info℠

Home

Help

Please Sign In

CymaBay Therapeutics, Inc. – ‘S-1MEF’ on 7/21/14 – EX-23.1

On: Monday, 7/21/14, at 9:18pm ET · Effective: 7/21/14 · Accession #: 1193125-14-274625 · File #s: 333-195127, 333-197548

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 7/21/14  CymaBay Therapeutics, Inc.        S-1MEF      7/21/14    3:46K                                    RR Donnelley/FA

Registration of Additional Securities — Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1MEF      Registration of Additional Securities               HTML     30K 
 2: EX-5.1      Opinion re: Legality                                HTML     11K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML      5K

EX-23.1 — Consent of Experts or Counsel

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Prepared by R.R. Donnelley Financial -- EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in this Registration Statement on Form S-1 of CymaBay Therapeutics, Inc. filed pursuant to Rule 462(b) of the Securities Act of 1933, as amended, of our report dated March 31, 2014 included in Amendment No. 1 to the Registration Statement on Form S-l of CymaBay Therapeutics, Inc. (File No. 333-195127), which was declared effective on July 21, 2014 by the Securities and Exchange Commission.

/s/ Ernst & Young LLP

Redwood City, California

July 21, 2014

Dates Referenced Herein and Documents Incorporated by Reference

This ‘S-1MEF’ Filing	Date	Other Filings

Filed on / Effective on:	7/21/14
	3/31/14	10-K, 10-Q
		List all Filings

↑Top